{"count": 4, "results": [{"_id": "33929389", "pmid": 33929389, "title": "Metformin Attenuates Hypoxia-induced Endothelial Cell Injury by Activating the AMP-Activated Protein Kinase Pathway.", "journal": "J Cardiovasc Pharmacol", "authors": ["Hu J", "Zheng Z", "Li X", "Li B", "Lai X", "Li N", "Lei S"], "date": "2021-06-01T00:00:00Z", "doi": "10.1097/FJC.0000000000001028", "meta_date_publication": "2021 Jun 1", "meta_volume": "77", "meta_issue": "6", "meta_pages": "862-874", "score": 50278.82, "text_hl": "Here, we investigated the role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Corneal_Endothelial_Cell_Loss @DISEASE_MESH:D055954 @@@endothelial cell injury@@@ and @<m>DISEASE_Fuchs</m>'<m>_Endothelial_Dystrophy</m> @DISEASE_MESH:D005642 @@@endothelial@@@-mesenchymal transition (EndMT) induced by @DISEASE_Hypoxia @DISEASE_MESH:D000860 @@@hypoxia@@@. ", "citations": {"NLM": "Hu J, Zheng Z, Li X, Li B, Lai X, Li N, Lei S. Metformin Attenuates Hypoxia-induced Endothelial Cell Injury by Activating the AMP-Activated Protein Kinase Pathway. J Cardiovasc Pharmacol. 2021 Jun 1;77(6):862-874. PMID: 33929389", "BibTeX": "@article{33929389, title={Metformin Attenuates Hypoxia-induced Endothelial Cell Injury by Activating the AMP-Activated Protein Kinase Pathway.}, author={Hu J and Zheng Z and Li X and Li B and Lai X and Li N and Lei S}, journal={J Cardiovasc Pharmacol}, volume={77}, number={6}, pages={862-874}}"}}, {"_id": "36322617", "pmid": 36322617, "title": "Nanoparticle-Reinforced Tough Hydrogel as a Versatile Platform for Pharmaceutical Drug Delivery: Preparation and in Vitro Characterization.", "journal": "Mol Pharm", "authors": ["Chakraborty A", "Pacelli S", "Alexander S", "Huayamares S", "Rosenkrans Z", "Vergel FE", "Wu Y", "Chakravorty A", "Paul A"], "date": "2023-01-02T00:00:00Z", "doi": "10.1021/acs.molpharmaceut.2c00564", "meta_date_publication": "2023 Jan 2", "meta_volume": "20", "meta_issue": "1", "meta_pages": "767-774", "score": 50277.7, "text_hl": "Cryogel-loaded @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduced the effect of @<m>DISEASE_Fuchs</m>'<m>_Endothelial_Dystrophy</m> @DISEASE_MESH:D005642 @@@endothelial@@@ cell injury caused by nutrient deprivation in vitro. ", "citations": {"NLM": "Chakraborty A, Pacelli S, Alexander S, Huayamares S, Rosenkrans Z, Vergel FE, Wu Y, Chakravorty A, Paul A. Nanoparticle-Reinforced Tough Hydrogel as a Versatile Platform for Pharmaceutical Drug Delivery: Preparation and in Vitro Characterization. Mol Pharm. 2023 Jan 2;20(1):767-774. PMID: 36322617", "BibTeX": "@article{36322617, title={Nanoparticle-Reinforced Tough Hydrogel as a Versatile Platform for Pharmaceutical Drug Delivery: Preparation and in Vitro Characterization.}, author={Chakraborty A and Pacelli S and Alexander S and Huayamares S and Rosenkrans Z and Vergel FE and Wu Y and Chakravorty A and Paul A}, journal={Mol Pharm}, volume={20}, number={1}, pages={767-774}}"}}, {"_id": "29461234", "pmid": 29461234, "title": "[INFLUENCE OF THE METFORMIN THERAPY ON THE ACTIVITY OF ENDOTHELIAL-DEPENDENT MEDIATORS AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CONCOMITANT TYPE 2 DIABETES MELLITUS].", "journal": "Georgian Med News", "authors": ["Zaikina Т", "Babadjan V", "Ryndina N", "Borzova O", "Kovalyova Y"], "date": "2018-01-01T00:00:00Z", "meta_date_publication": "2018 Jan", "meta_volume": "", "meta_issue": "274", "meta_pages": "92-97", "score": 50093.375, "text_hl": "[INFLUENCE OF THE @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@METFORMIN@@@ THERAPY ON THE ACTIVITY OF @<m>DISEASE_Fuchs</m>'<m>_Endothelial_Dystrophy</m> @DISEASE_MESH:D005642 @@@ENDOTHELIAL@@@-DEPENDENT MEDIATORS AMONG PATIENTS WITH @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@ACUTE MYOCARDIAL INFARCTION@@@ AND CONCOMITANT @DISEASE_Diabetes_Mellitus_Noninsulin_Dependent_2 @DISEASE_MESH:C563323 @@@TYPE 2 DIABETES MELLITUS@@@].", "citations": {"NLM": "Zaikina Т, Babadjan V, Ryndina N, Borzova O, Kovalyova Y. [INFLUENCE OF THE METFORMIN THERAPY ON THE ACTIVITY OF ENDOTHELIAL-DEPENDENT MEDIATORS AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CONCOMITANT TYPE 2 DIABETES MELLITUS]. Georgian Med News. 2018 Jan;(274):92-97. PMID: 29461234", "BibTeX": "@article{29461234, title={[INFLUENCE OF THE METFORMIN THERAPY ON THE ACTIVITY OF ENDOTHELIAL-DEPENDENT MEDIATORS AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CONCOMITANT TYPE 2 DIABETES MELLITUS].}, author={Zaikina Т and Babadjan V and Ryndina N and Borzova O and Kovalyova Y}, journal={Georgian Med News}, number={274}, pages={92-97}}"}}, {"_id": "10576529", "pmid": 10576529, "title": "Prevention of type 2 diabetes: role of metformin.", "journal": "Drugs", "authors": ["Charles MA", "Eschwège E"], "date": "1999-01-01T00:00:00Z", "doi": "10.2165/00003495-199958001-00015", "meta_date_publication": "1999", "meta_volume": "58 Suppl 1", "meta_issue": "", "meta_pages": "71-3; discussion 75-82", "score": 50089.86, "text_hl": "In addition, it has demonstrated favourable action on several cardiovascular risk factors that are often present in these individuals: it favours the maintenance of diet-induced @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ and its associated improvement in fibrinolysis; and it lowers plasma concentrations of fasting @GENE_INS @GENE_3630 @@@insulin@@@, total and low density lipoprotein-cholesterol, @CHEMICAL_Fatty_Acids_Nonesterified @CHEMICAL_MESH:D005230 @@@free fatty acids@@@, and of two markers of @<m>DISEASE_Fuchs</m>'<m>_Endothelial_Dystrophy</m> @DISEASE_MESH:D005642 @@@endothelial@@@ damage--tissue plasminogen activator antigen and @GENE_VWF @GENE_7450 @@@von Willebrand factor@@@. ", "citations": {"NLM": "Charles MA, Eschwège E. Prevention of type 2 diabetes: role of metformin. Drugs. 1999;58 Suppl 1():71-3; discussion 75-82. PMID: 10576529", "BibTeX": "@article{10576529, title={Prevention of type 2 diabetes: role of metformin.}, author={Charles MA and Eschwège E}, journal={Drugs}, volume={58 Suppl 1}, pages={71-3; discussion 75-82}}"}}]}